Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

• Tarsus Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 162.1 M, a 106.87% increase year-over-year.
• Tarsus Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 461.7 M, a 289.94% increase year-over-year.
• Tarsus Pharmaceuticals Inc. annual revenue for 2025 was 451.4 M, a 146.71% increase from 2024.
• Tarsus Pharmaceuticals Inc. annual revenue for 2024 was 183.0 M, a 948.62% increase from 2023.
• Tarsus Pharmaceuticals Inc. annual revenue for 2023 was 17.4 M, a 32.42% decrease from 2022.
• Tarsus Pharmaceuticals Inc. annual revenue for 2022 was 25.8 M.